Dec. 28, 2015, 12:41 PM
- Venture capital outfit Harris & Harris (TINY -0.5%) receives $2.1M from the achievement of an undisclosed milestone associated with Amgen's acquisition of BioVex Group in March 2011. The payment increases its total gross proceeds from the sale to ~$12.8M, more that triple its original investment of ~$4M. Its return could increase by another $5.4M upon the achievement of additional undisclosed milestones.
Harris & Harris Group, Inc. (New York) is a business development company that makes venture capital investments in science-enabled companies, particularly those that are commercializing or integrating products enabled by nanotechnology or micro systems. The fund focuses on companies operating in... More
Industry: Diversified Investments
Country: United States